Puma Biotechnology (PBYI) Income towards Parent Company (2010 - 2026)
Puma Biotechnology's Income towards Parent Company came in at $8.19 million for Q2 2026, up 39.9% from $5.86 million a year earlier.
Powered by 
Analysis
Puma Biotechnology (PBYI) Income towards Parent Company (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Puma Biotechnology reported Income towards Parent Company of $26.64 million, down 45.0% year-over-year; for FY2025, it was $31.11 million, up 2.8% from FY2024.
- Going back by year, Income towards Parent Company was $30.28 million in FY2024 (+40.2%), $21.59 million in FY2023, $2,000 in FY2022 and -$29.13 million in FY2021.
- The five-year range for quarterly Income towards Parent Company is -$44.67 million (Q3 2021) to $20.32 million (Q3 2024).
- Year-over-year, Income towards Parent Company increased in three of the last five quarters, with growth averaging 52.2%.
- Business Quant data shows PBYI's Income towards Parent Company at -$3.8 million (Q1 2026), $13.41 million (Q4 2025) and $8.84 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Puma Biotechnology | 485.99 Mn | 98.62 Mn | 44.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.19 Mn |
| Mar 31, 2026 | -3.80 Mn |
| Dec 31, 2025 | 13.41 Mn |
| Sep 30, 2025 | 8.84 Mn |
| Jun 30, 2025 | 5.86 Mn |
| Mar 31, 2025 | 2.97 Mn |
| Dec 31, 2024 | 19.31 Mn |
| Sep 30, 2024 | 20.32 Mn |
| Jun 30, 2024 | -4.53 Mn |
| Mar 31, 2024 | -4.82 Mn |
| Dec 31, 2023 | 12.27 Mn |
| Sep 30, 2023 | 5.80 Mn |
| Jun 30, 2023 | 2.13 Mn |
| Mar 31, 2023 | 1.40 Mn |
| Dec 31, 2022 | -5.61 Mn |
| Sep 30, 2022 | -360,000.00 |
| Jun 30, 2022 | 9.37 Mn |
| Mar 31, 2022 | -3.40 Mn |
| Dec 31, 2021 | 4.22 Mn |
| Sep 30, 2021 | -44.67 Mn |
API Access
Puma Biotechnology Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=PBYI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "PBYI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=PBYI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();